ArticleNonlinear dynamics2021
Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models.
Article in Nonlinear dynamics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Interval type-2 Fuzzy control and stochastic modeling of COVID-19 spread based on vaccination and social distancing rates.Computer methods and programs in biomedicine · 2023Article
- Uncertainty quantification in mechanistic epidemic models via cross-entropy approximate Bayesian computation.Nonlinear dynamics · 2023Article
- Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany.BMC infectious diseases · 2022Article
- Data analysis and prediction of the COVID-19 outbreak in the first and second waves for top 5 affected countries in the world.Nonlinear dynamics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, various countries from across the globe have been facing the second wave of COVID-19 infections. In order to understand the dynamics of the spread of the disease, much effort has been made in terms of mathematical modeling. In this scenario, compartmental models are widely used to simulate epidemics under various conditions. In general, there are uncertainties associated with the reported data, which must be considered when estimating the parameters of the model. In this work, we propose an effective methodology for estimating parameters of compartmental models in multiple wave scenarios by means of a dynamic data segmentation approach. This robust technique allows the description of the dynamics of the disease without arbitrary choices for the end of the first wave and the start of the second. Furthermore, we adopt a time-dependent function to describe the probability of transmission by contact for each wave. We also assess the uncertainties of the parameters and their influence on the simulations using a stochastic strategy. In order to obtain realistic results in terms of the basic reproduction number, a constraint is incorporated into the problem. We adopt data from Germany and Italy, two of the first countries to experience the second wave of infections. Using the proposed methodology, the end of the first wave (and also the start of the second wave) occurred on 166 and 187 days from the beginning of the epidemic, for Germany and Italy, respectively. The estimated effective reproduction number for the first wave is close to that obtained by other approaches, for both countries. The results demonstrate that the proposed methodology is able to find good estimates for all parameters. In relation to uncertainties, we show that slight variations in the design variables can give rise to significant changes in the value of the effective reproduction number. The results provide information on the characteristics of the epidemic for each country, as well as elements for decision-making in the economic and governmental spheres.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.